Familial hypercholesterolaemia (FH) accelerates atherosclerotic cardiovascular disease (ASCVD) and accordingly is the most potent hereditary cause of premature coronary heart disease. The association between telomere length (TL), a biological index of ageing, and FH has not been hitherto investigated. We addressed this question using data from the US National Health and Education National Surveys (NHANES, 1999(NHANES, -2002. 
Introduction
Familial hypercholesterolaemia (FH) is a syndrome that causes defective clearance of low-density lipoprotein cholesterol (LDL-C) and premature coronary heart disease (CHD). 1, 2 The majority of cases have the autosomal dominant pattern of inheritance with 90% penetrance. [1] [2] [3] Autosomal dominant FH is attributed to mutations in three different genes: low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9). 1, 2 Despite being the most common monogenic disorder, FH remains widely underdiagnosed and undertreated worldwide. 3 Telomeres are nucleotide sequences located at the ends of chromosomes that assist in the preservation of chromosomal mechanical reliability and genomic consistency. 4 It has been reported that telomere length (TL) of replicating somatic cells is inversely associated with age and non-communicable disease, such as cardiovascular disease (CVD), chronic kidney disease, obesity, hypertension (HTN), or diabetes mellitus (DM). [4] [5] [6] [7] [8] [9] [10] [11] Normal telomere maintenance requires the cellular enzyme telomerase that adds telomeric DNA, thereby preserving TL and normal cellular function. 12 During mitosis, DNA loses telomeric repeats with an estimated shortening rate of 25 base pairs per year, eventually causing replicative cell senescence. 13 Furthermore, accelerated shortening of the TL might be the consequence of increased exposure to oxidative stress and inflammatory mediators, such as C-reactive protein (CRP). [14] [15] [16] Hence, TL is often used as a cellular marker for biological age, with shorter telomeres indicating increased age. Shortened telomeres could also impair metabolism through various molecular mechanisms, such as increased inflammation, sympathetic nervous system activity, and oxidative damage. 17, 18 We have also recently found a positive association between highdensity lipoprotein cholesterol (HDL-C) and TL, 7 consistent with previous reports. [19] [20] [21] [22] Markedly elevated plasma concentration of LDL-C is the hallmark of FH and the driver of premature atherosclerotic cardiovascular disease (ASCVD). However, the relationship between telomere biology and FH has not been previously investigated.
A possible link may relate to increased generation of reactive oxygen species (ROS) in FH, 23 which may in turn shorten TL. 7, 15 In the present study, we, therefore, aimed to investigate the association between TL and FH in a national representative sample of US adults. We hypothesized that individuals with a phenotypic diagnosis of FH have a shorter TL, and given that TL is considered as a biomarker of premature ageing, we also hypothesized that a lower TL may be a feature of FH.
Methods

NHANES study information
The National Health and Education National Surveys (NHANES) are ongoing repeated cross-sectional studies conducted by the US National Center for Health Statistics (NCHS). 24 The NHANES use a multistage probability sampling strategy, which oversamples certain subgroups of the population, including Afro-Americans, Mexican-Americans, and those of lower socioeconomic status. NCHS Research Ethics Review Board approved the NHANES protocol, and consent was obtained from all participants. 24 Data collection on demographic information occurs through in-home administered questionnaires, while anthropometric, inflammation, and biochemistry data are collected by trained using mobile examination units. More detailed information is available elsewhere.
24,25
Participants and clinical measurements , and obesity being defined as BMI > _30 kg/m 2 . Plasma lipid profiles were measured from morning peripheral blood draws fasting. Serum total cholesterol and triglycerides (TGs) were measured enzymatically, HDL-C by direct immunoassay or by precipitation, 26 and LDL-C was calculated by the Friedewald equation if the TGs level was < _4.5 mmol/L (400 mg/dL). 27 The NHANES collected self-reported personal history of ASCVD, including age at onset of disease. These variables were used to derive an indicator for early ASCVD, defined as CHD, angina or heart attack, or stroke at < _55 years of age in men and < _60 years of age in women. Hypertension was diagnosed as systolic blood pressure > _140 mmHg and as diastolic blood pressure > _90 mmHg. Individuals who were on antihypertensive medications were also considered as HTN. 28 Type 2 diabetes (T2DM) was defined as a self-reported diagnosis or fasting plasma glucose > _126 mg/dL. 29 Current smokers were defined as individuals who reported having smoked at least 100 cigarettes in their lives and reported currently smoking every day or some days. 29 
Measurement of telomere length
The measurement of TL has been reported elsewhere. [5] [6] [7] [8] 15, 16 In brief, using the Puregene (D-50 K) kit protocol, samples of purified DNA were isolated from whole blood (Gentra Systems, Inc., Minneapolis, MN, USA). The TL assay was performed using the quantitative polymerase chain reaction method, with TL measured relative to reference DNA standard [i.e. the telomere-to-single (T/S) ratio]. 30 Control DNA values were used to normalize between-run variability. Runs with more than four control DNA values falling outside 2.5 SD from the mean for all assay runs were excluded from further analysis (<6% of runs). For each sample, any potential outliers were identified and excluded from the calculations (<2% of samples). The interassay coefficient of variation was 6.5%. 24, 30 The Centers for Diseases Control (CDC) granted human subject approval for this measure through CDC Institutional Review Board and also assured a quality control of the TL measurements prior to data linkage with the NHANES database. 25 
Definition of familial hypercholesterolaemia
The Dutch Lipid Clinic Network (DLCN) criteria were employed the define FH. 31 The diagnosis was based on points for LDL-C levels [graded from 8 points for LDL >8.5 mmol/L (330 mg/dL) down to 1 point for 4.0-4.9 mmol/L (155-189 mg/dL)], personal history of early ASCVD (2 points), and high LDL-C (>95th percentile for age, sex, and country) in a first-degree relative (1 point each). 32 For individuals reporting statin use, we multiplied their LDL-C level by 1.43 to estimate untreated LDL-C levels, as proposed by Benn et al. 33 and Edwards and Moore. 34 This is corresponding to an estimated 30% reduction in LDL-C. [33] [34] [35] This adjustment is an approximation and might have introduced a bias; however, this correction factor is in a line with previously published data, [35] [36] [37] and it has been already used in another analyses of FH population based on NHANES study. 23, 38 Individuals were classified as having definite FH (>8 points), probable FH (6-8 points), possible FH (3-5 points), or unlikely FH (<3 points). 31 Family history of hypercholesterolaemia, personal history of peripheral arterial disease, physical stigmata of FH, and presence of pathogenic mutation were not collected in NHANES and were not employed to diagnose FH.
Statistical analysis
We conducted the statistical analyses according to the guidelines of the CDC for analysis of complex National Health and Nutrition Examination Survey (NHANES) datasets, accounting for marked variance and using the proposed weighting methodology. Continuous and categorical demographic variables were compared by using analysis of variance and v 2 tests, respectively. We compared TL between positive (FH) and negative (non-FH) subjects using analysis of covariance, with adjustments for age, sex, race, BMI, and CRP as covariates.
Multiple logistic regression was employed to analyse the association between a diagnosis of FH and TL categories, adjusting for age, sex, race, BMI, and CRP; results were expressed as odds ratio (OR) and 95% confidence interval (95% CI). Sample weights were applied to account for unequal probabilities of selection, non-response bias, and oversampling. All tests were two-sided, and P < 0.05 is the level of significance. All analyses were carried out using SPSS complex sample module version 22.0 (IBM Corp, Armonk, NY, USA).
Results
The characteristics of the overall sample population and subjects meeting the criteria for FH (probable þ definite FH) are described in The overall adult US prevalence of total FH in NHANES was 0.43% (95% CI 0.33-0.57, mean DLCN score 6.8) ( Table 2) . The mean TL in the non-HF population was 1.09 (95% CI 1.06-1.12) (T/S ratio) and 1.09 (1.03-1.12) (T/S ratio) in the FH individuals. We compared adjusted (for age, sex, race, BMI, and CRP) TL between positive and negative FH subjects and it turned out that subjects with FH had shorter TL [0.89, 95% CI 0.84-0.93 (T/S ratio)] compared with non-FH individuals [1.05, 95% CI 0.97-1.11 (T/S ratio); P < 0.001] ( Table 2) . Further, we computed adjusted likelihood of FH based on quartile of TL and found that subjects with longer telomere (Q4) had 12% lower chance of FH (OR 0.88, 95% CI 0.78-0.93) compared with Q1 quartile (considered as reference) with insignificant trend between quartiles (P = 0.069).
Discussion
By applying a large and nationally representative, randomly selected sample of American adults, we found for the first time that adjusted TL was significantly shorter in FH subjects compared with the healthy ones. Individuals with longer TL had 12% lower chance of FH compared with the shortest TL (Q1 quartile-reference). This finding is in the line with current knowledge suggesting that in FH patients high LDL-C levels is a lifelong risk factor for ASCVD and we need to optimize cholesterol-lowering therapy early on to prolong the lifespan comparable to the background population. [1] [2] [3] [4] Familial hypercholesterolaemia is due to a group of genetic disorders that result in abnormally high LDL-C levels that cause atherosclerotic plaque deposition in arteries and a markedly increased CHD risk at a young age (even 100Â higher at age 20-40 years). It is estimated that there are over 13 million individuals with FH globally, and only in USA there are >600 000 FH patients. 1 The majority of patients with FH are either untreated or undertreated. 1 In vertebrates, the telomeric DNA consists of 5 0 -TTAGGG-3 0 repeats in the strand that contains the 3 0 end. 10, 11 Our findings support the hypothesis that significantly shorter TL in FH subject could be due to higher oxidative stress, noting that TL is sensitive to oxidative modification. 18, 40, 41 Higher oxidative stress and ROS production in subjects with FH may be due to several factors 23 ( Figure 1 ), including the impact of very high levels of cholesterol in lowering the bioavailability tetrahydrobiopterin and promoting the generation of superoxide radicals. 42 Hypercholesterolaemic patients also have reduced bioavailability of NO due to the inactivation of NO by superoxide radicals. 43 Further, FH subject have high levels of oxidized LDL (oxLDL) that could damage DNA. 43, 44 Increased oxidative stress in FH may reduce the levels of asymmetric dimethylarginine, an endogenous of nitric oxide synthase, and dimethylarginine and dimethylaminohydrolase 44, 45 ( Figure 1) . Further, oxLDLs may trigger inflammation by different mechanisms, including activation of nuclear factor kappa-B-like transcription factors 46 and this may be compounded by the generation of reactive nitrogen species such as dinitrogen trioxide (N 2 O 3 ) and peroxynitrite (ONOO -) 47 ( Figure 1) .
Nitrosation of protein thiols by N 2 O 3 and the nitration of aromatic amino acids (e.g. tyrosine) by ONOO -can in turn impair protein synthesis (i.e. up-regulation of adhesion molecules and production of chemokines) and further promote oxidative stress and inflammation, accelerating telomere shortening. An additional pathobiological mechanism invokes an autoimmune response to oxLDLs, which could further amplify the inflammatory response. 48 The expression and activity of antioxidants and antioxidant enzymes (especially reduced glutathione, superoxide dismutase, and catalase), as well as miR-25 (protective against oxidative stress) activity are also decreased in hypercholesterolaemia. [49] [50] [51] There are therefore multiple aetiologies for higher oxidative stress in FH subjects that could explain shortening of TL ( Figure 1) . Previous studies found that FH subjects have lower plasma CRP levels than controls 52 ( Figure 1) . Higher CRP in FH may reflect lower increased inflammation and oxidative stress. After adjustment for CRP, we found significant difference in TL between FH and non-FH subjects in the present study, pointing to other mechanisms beyond inflammatory factors. Malondialdehyde, an end product of lipid peroxidation, has been also reported to be increased in FH subjects and can induce DNA damage. 46 The study has limitations. Because the number of patients with FH was relatively small, the results should be treated as preliminary. However, we emphasized that we provide the only available data on FH subjects and TL in a multi-ethnic sample population. Atherosclerotic cardiovascular disease events were self-report, which is less reliable than adjudicated events. We have corrected LDL-C level for statin use by multiplying to the pre-specified number, which was already validated. 23, 33, 34, 38 We adjust our statistical models for most confounders, but cannot exclude residual bias. We concede that many patients with probable phenotypic FH do not bear pathogenic mutations and or a definite FH phenotype; our patients might have had familial combined hyperlipidaemia or polygenic hypercholesterolaemia, so that further studies in genetically defined patients are warranted. 51 Only a small proportion of FH subjects reported treatment with statins (11%), and owing to this we were not able to investigate the potential role of statins in protecting against telomere shortening.
52-54
These preliminary data shed light on the link between FH and TL; we have found FH subjects have significantly shorter length of telomere. An increased oxidative stress due to hypercholesterolaemia could result in shorter TL, and this could reflect the impact of the burden of cholesterol-life years. Our study has public health and clinical implications. The findings provide a link between FH and a biological index of accelerated aging, noting that untreated FH markedly curtails life expectancy. This supports increased efforts to start effective therapy in early life to prevent the impact high LDL-C levels on premature ASCVD, ageing, and mortality. Further investigations with larger number of genetically confirmed cases and matched controls are necessary to address the presented hypothesis on the association between FH and TL, which might improve our understanding of the pathobiology of FH and its influence on premature aging.
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